Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_assertion description "[Since IL-1 and TNF-alpha are related to inflammation and their immunoexpression increases in PC, inhibition of these cytokines might be a possible target for PC treatment, because they decrease the activity of all transduction pathway members that activate transcription factors such as NF-kappaB, Elk-1 or ATF-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_assertion evidence source_evidence_literature NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_assertion SIO_000772 18752500 NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_assertion wasDerivedFrom befree-2016 NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_assertion wasGeneratedBy ECO_0000203 NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.
- befree-2016 importedOn "2016-02-19" NP690078.RAvbGDn0oBd2C9lwtVuJO48MIWfTHOZWsRhwiqEUGAdS0130_provenance.